Efficacy Of Gabapentin In Trigeminal Neuralgia: A Non-randomized Trial

Authors

  • Nasir Ali Khan
  • Samia Siraj
  • Usman Mahmood
  • Fauzia Sidiqui
  • Daud Mirza
  • Muhammad Shahrukh Khan Sadiq
  • Beenish Fatima Alam

DOI:

https://doi.org/10.51985/JBUMDC2018045

Keywords:

Trigeminal Neuralgia, carbamazepine, Gabapentin

Abstract

Objective: To compare the efficacy of Gabapentin with carbamazepine in Trigeminal Neuralgia.
Material/Method: The study was conducted in Agha Khan University Hospital and Abbasi Shaheed Hospital for four
months. 19 patients of TN were collected through purposive convenience sampling. DN4 questionnaire was used to
differentiate between Somatic and Neuropathic pain. Numeric Pain Rating Scale was used to assess the severity of pain.
Results: Nine patients of Trigeminal Neuralgia refractory to carbamazepine were put on Gabapentin with male to female
ratio of 4:5. All showed favorable response on 800-1600 mg Gabapentin on Numeric Pain Rating Scale. All patients were
pain free in three weeks with no side effects. There was significant difference between pain response to carbamazepine
and Gabapentin at P< .05. Four patients (44%) had pain relief on 900 mg Gabapentin, three (33%) on 1200 mg, one
responded on 800 mg and one on 1600 mg.
Conclusion: Gabapentin is effective as first line treatment in Trigeminal Neuralgia

References

Katsuhiro Toda, Trigeminal Neuralgia —Symptoms, Diagnosis,

Classification, and Related Disorder, Oral Science International,

vol. 4, no. 1, pp. 1–9, 2007.

Zvartau-Hind M, Din MU, Gilani A, Lisak RP, Khan OA.

Topiramate relieves refractory trigeminal neuralgia in MS

patients. Neurology. 2000;55(10):1587-8.

Bennetto L, Patel NK, Fuller G. Trigeminal neuralgia and its

management. BMJ. 2007;334(7586):201-5.

Mackey S, Feinberg S. Pharmacologic therapies for complex

regional pain syndrome. Curr Pain Headache Rep.

;11(1):38-43.

Campbell JK. Trigeminal neuralgia: are all of the treatment

options being considered?. Headache. 1997; 37(1):H3.

Love S, Coakham HB. Trigeminal neuralgia: pathology and

pathogenesis. Brain. 2001;124:2347–60.

Cheshire WP Jr. The shocking tooth about trigeminal neuralgia.

N Engl J Med. 2000;342(26):2003.

Chole R, Patil R, Degwekar SS, Bhowate RR. Drug treatment

of trigeminal neuralgia: a systematic review of the literature.

J Oral Maxillofac Surg. 2007;65(1):40-5.

Devor M, Amir R, Rappaport ZH. Pathophysiology of

trigeminal neuralgia: the ignition hypothesis. Clin J Pain.

;18:4–13.

Jackson EM, Bussard GM, Hoard MA, Edlich RF. Trigeminal

neuralgia: a diagnostic challenge. Am J Emerg Med.

;17(6):597-600.

Hassan S, Khan NI, Sherwani OA, Bhatt W, Asif S. Trigeminal

neuralgia: an overview of literature with emphasis on medical

management. Int Research J Pharmcol. 2013;3:235–238.

Reddy GD, Viswanathan A. Trigeminal and glossopharyngeal

neuralgia. Neurol Clin. 2014;32(2):539–552.

Zakrzewska JM, Linskey ME. Trigeminal neuralgia. BMJ.

;348:g474.

Cruccu G. Trigeminal neuralgia. Continuum (Minneap Minn)

;23:396–420. 2, Selected Topics in Outpatient Neurology

Kubitz PK, Wijdicks EF, Bolton CF. Tic douloureux or "tic

dentaire". Neurology. 2004;62(2):333.

Liu JK, Apfelbaum RI. Treatment of trigeminal neuralgia.

Neurosurg Clin N Am. 2004;15(3):319-34.

Obermann M, Yoon MS, Sensen K, et al. Efficacy of pregabalin

in the treatment of trigeminal neuralgia. Cephalalgia.

;28:174–181.

Rozen TD. Antiepileptic drugs in the management of cluster

headache and trigeminal neuralgia. Headache. 2001;41:

S25–S32.

Rasche D, Kress B, Schwark C, Wirtz CR, Unterberg A,

Tronnier VM. Treatment of trigeminal neuralgia associated

with multiple sclerosis: case report. Neurology. Nov 9

;63(9):1714-5.

Joffroy A, Levivier M, Massager N. Trigeminal neuralgia.

Pathophysiology and treatment. Acta Neurol Belg.

;101:20–25.

Keppel Hesselink JM, Schatman ME. Phenytoin and

carbamazepine in trigeminal neuralgia: marketing-based versus

evidence-based treatment. Journal of Pain Research.

;10:1663-1666.

Ghita Harifi, Imane Ouilki. Validity and Reliability of the

Arabic Adapted Version of the DN4 Questionnaire (Douleur

Neuropathique 4 Questions) for Differential Diagnosis of

Pain Syndromes with a Neuropathic or Somatic Component.

Pain Pract. 2011;11(2):139-47.

Cleland JA, Childs JD and Whitman JM, Psychometric

properties of the Neck Disability Index and Numeric Pain

Rating Scale in patients with mechanical neck pain. Arch

Phys Med Rehabil. 2008;89(1):69-74.

Cheshire WP., Jr Defining the role for gabapentin in the

treatment of trigeminal neuralgia: a retrospective study. J

Pain. 2002;3:137–142

Serpell MG Neuropathic pain study group. Gabapentin in

neuropathic pain syndromes: a randomised, double-blind,

placebo-controlled trial. Pain. 2002;99:557–566.

George M, Selvarajan S, Indumathi C. Drug therapy for

trigeminal neuralgia. e-Journal of Dentistry. 2011;1:28–31.

Anand KS, Dhikav V, Prasad A, Shewtengna. Efficacy, safety

and tolerability of duloxetine in idiopathic trigeminal neuralgia.

J Indian Med Assoc. 2011;109(4):264-6

Downloads

Published

2021-03-21

How to Cite

Nasir Ali Khan, Samia Siraj, Usman Mahmood, Fauzia Sidiqui, Daud Mirza, Muhammad Shahrukh Khan Sadiq, & Beenish Fatima Alam. (2021). Efficacy Of Gabapentin In Trigeminal Neuralgia: A Non-randomized Trial. Journal of Bahria University Medical and Dental College, 8(3), 151–154. https://doi.org/10.51985/JBUMDC2018045

Issue

Section

Original Articles